NCT02871037View on ClinicalTrials.gov

Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Normal Healthy

Interventions

DRUG

PF-05221304

Single or repeated, escalating dose of PF-05221304

OTHER

Placebo

single or repeated dose of placebo

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY